Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Discover the difference between burnout vs depression, including causes, symptoms, and how both are treated, according to ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...

The winter blues, on the other hand, are less serious. They usually don’t involve thoughts of hopelessness or suicide, but ...

The 19-year-old, who is the youngest daughter of Charlie Sheen and Denise Richards, revealed that her “deep depression” led ...

Using computational models, the researchers studied how the brain's reward-learning system functions in those with depression, especially among individuals experiencing anhedonia, the inability to ...

A large study found that men lost seven years of life expectancy and women lost nine years, compared with counterparts ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...